NCT05189847Completed
Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis
Clinical Register Studying the therApeutic Patient Population With Multifocal Atherosclerosis in the Russian Federation and Eurasian Countries
Source: ClinicalTrials.gov · Last updated 26 Jun 2024
Brief summary (registry, in English)
Аn international, multicenter, non-interventional real-life clinical practice Register studying the Actual therapeutic patient population with Multifocal Atherosclerosis in the Russian Federation and Eurasian countries
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 3059 (actual)
- First submitted
- 28 Dec 2021
- Start date
- 1 Feb 2022
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- Eurasian Association of Therapists
- NCT number
- NCT05189847
What you commit to
- Study type: Observational
- Participants enrolled: 3059
- From 1 Feb 2022 to the primary completion date, 31 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Life expectancy less than 1 year;
- Patient refusal to participate in the Register
Who the study is looking for
- Men or women aged 18 and older at the time of data registration; Presence of 2 or more of the following factors
- Coronary arteries atherosclerosis (atherosclerosis revealed by means of coronary angiography and/or a history of type I myocardial infarction and/or elective PCI and/or CABG and/or angina pectoris with ischemia according to stress test results, history of CHD);
- Lower extremity arteries atherosclerosis (atherosclerotic plaques revealed by ultrasound, and/or ABI \<0.9, and/or a history of revascularization, and/or a history of amputation associated due to chronic lower extremities arterial insufficiency);
- Atherosclerosis of brachiocephalic arteries or renal arteries (presence of atherosclerotic plaques according to US data and/or history of revascularization and/or history of atherothrombotic stroke or TIA in the absence of known AF);
- Atherosclerosis of renal arteries or abdominal aorta (presence of atherosclerotic plaques according to US data and/or history of revascularization).
- Presence of one or more of the following atherosclerotic risk factors:
- Anamnestic data on dyslipidemia with LDL cholesterol levels above 4.9 mmol/L or total cholesterol levels above 8.0 mmol/L;
- Presence of confirmed familial hypercholesterolemia;
- Current smoker status or history of smoking;
- Overweight (BMI≥ 25 kg/m2);
- Presence of arterial hypertension;
- Presence of established type 2 diabetes mellitus;
- Presence of an established diagnosis of prediabetes;
- Presence of CKD stage 3a and higher (GFR \<60 ml / min / 1.73 m2).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eurasian Association of Therapists Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.